Announcements Trials
Browse Landscape

Phase

Phase 1 26Phase 2 23Phase 3 20Phase 4 18Phase 1/2 8Phase EARLY_PHASE1 6Phase NA 5Phase 2/3 4

Status

Unknown 3Withdrawn 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 4Dermatologic 1

Conditions

Uterine Cervical Dysplasia 3Vulvar Neoplasms 1Keratosis, Actinic 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Interventional × Imiquimod × Clear all
NCT04859361 2021-05-03

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

University Medical Centre Maribor

Phase NA Unknown
104 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00814528 2018-09-10

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

University of Chicago

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

NCT02917746 2018-08-16

TOPIC-3

Maastricht University Medical Center

Phase NA Unknown
120 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00504023 2018-06-06

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Memorial Sloan Kettering Cancer Center

Phase NA Completed
8 enrolled 7 charts
Gynecologic

Vulvar Neoplasms

NCT03206138 2017-07-02

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Seoul St. Mary's Hospital

Phase NA Unknown
50 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡